Intermittent Claudication
📧 Sign up to get email alerts when something new happens for Intermittent Claudication.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients [NA]
Clinical trial update on acute cardiovascular responses and chronic adaptations to strength exercise in patients with intermittent claudicat…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: The PaWS (Pedometer and Walking Study) [NA]
This is an update on the PaWS (Pedometer and Walking Study) clinical trial (NCT02510807) sponsored by University Health Network in Toronto, …
-
FDA approval · 2016-04-04FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)
The FDA approval of a supplemental application for cilostazol from Apotex Corp., enabling continued generic supply under the approved scope.
-
FDA approval · 2016-04-04FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Cilostazol from Chartwell RX, LLC under an ANDA.
-
FDA approval · 2016-04-04FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc. This action updates the regulatory status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-04FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for cilostazol from Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2016-02-09Clinical Trial Update: The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication [Phase 4]
A Phase 4 clinical trial evaluating metformin’s impact on functional capacity in individuals with peripheral arterial disease-related interm…
-
FDA approval · 2016-01-21FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for pentoxifylline filed by Rising Pharma Holdings, Inc., indicating an update to its regulatory…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: VISIBILITY™ Iliac Study [NA]
Clinical trial update for the VISIBILITY Iliac study (NCT01402700) by Medtronic Endovascular indicates completion of the peripheral arterial…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Intensive Rehabilitation in Peripheral Arterial Disease With Claudication: Effects of a Treadmill Training With Active Recovery [Phase 3]
This Phase 3 clinical trial update reports the results of intensive treadmill rehabilitation with active recovery in patients with periphera…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: DURABILITY™ Iliac Study [NA]
This entry reports the completion and posted results of Medtronic Endovascular's DURABILITY Iliac trial for peripheral arterial disease with…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain) [Phase 1]
Phase 1 clinical trial update assessing autologous CD34+ stem cell injections for severe intermittent claudication in peripheral artery dise…
-
CLINICAL_TRIALS research · 2015-03-05Clinical Trial Update: Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) [Phase 1, Phase 2]
Clinical trial update on the safety study of MultiGeneAngio for peripheral arterial disease, including intermittent claudication, in Phase 1…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND) [Phase 4]
Phase 4 trial comparing a self-expanding nitinol stent to percutaneous transluminal angioplasty with optional bailout stenting in symptomati…
-
FDA approval · 2014-12-31FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Cilostazol (generic Cilostazol). This action typically involves u…
-
FDA approval · 2014-11-06FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for cilostazol submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to the drug's l…
-
CLINICAL_TRIALS withdrawal · 2014-10-15Clinical Trial Update: Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients [Phase 4]
A Phase 4 clinical trial investigating adenosine-induced myocardial blood flow in patients with peripheral artery disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: ARREST PAD (Peripheral Arterial Disease) [Phase 2, Phase 3]
Clinical trial update for ARREST PAD indicates Phase 2 and Phase 3 studies in peripheral artery disease (intermittent claudication and relat…
-
FDA approval · 2014-09-23FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cilostazol from Teva Pharmaceuticals USA, Inc., updating the labeling for the drug. This constit…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis [NA]
This is a completed safety and effectiveness trial of the EverFlex Stent for symptomatic femoropopliteal atherosclerosis; results from the p…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. [Phase 4]
Phase 4 trial update examining resistance to aspirin and/or clopidogrel in patients with peripheral arterial disease presenting with intermi…
-
CLINICAL_TRIALS research · 2013-11-11Clinical Trial Update: Effect of Exercise on Patients With Claudication Undergoing Surgery [NA]
This clinical trial update from the University of Hull examines whether exercise affects outcomes for patients with intermittent claudicatio…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: 4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease [Phase 4]
Phase 4 trial update showing completed status for safety evaluation of 4F Endovascular Treatment in infra-inguinal arterial stenotic disease…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Evaluation of Cilostazol in Combination With L-Carnitine [Phase 4]
Phase 4 trial evaluating cilostazol in combination with L-carnitine for intermittent claudication due to peripheral vascular disease.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions [Phase 4]
Phase 4 trial update for iliac stents to treat TASC A-D iliac artery lesions; the study status is Completed.